Efficacy and safety of olaparib monotherapy in germline BRCA1 / 2 mutation carriers with advanced ovarian cancer and three or more lines of prior therapy

Susan M. Domchek, Bella Kaufman, Georgeta Fried et al.|Gynecologic Oncology|2015

Cited by 300